Molecular Crosstalk between Artificial Sweetener Aspartame and Diabetes-Linked Insulin Hormone Unveils Possible Amyloidosis Risks
Biomacromolecules · 2025
DOI: 10.1021/acs.biomac.5c00286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Masihuzzaman Ansari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biophysical and Biomaterials Research Laboratory, Room 310, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India. Hauptthemen laut MEDLINE: Aspartame, Sweetening Agents, Insulin, Amyloidosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
An important adaptation for diabetes patients is the consumption of artificial sweetener aspartame, which is present in more than thousands of food products and medicines. Several studies have shown diverse side effects of aspartame, and it is also known to form amyloid-like cytotoxic and cross-seeding-competent nanostructures. Here, we reveal a direct crosstalk between aspartame and insulin that induces their cross-seeding and coaggregation events. Insulin’s cross-β structure possesses high affinity for aspartame and triggers its self-assembly into cytotoxic nanostructures. Likewise, aspartame nanostructures were found to trigger the amyloid aggregation of insulin. The coaggregates of aspartame and insulin display amyloid-like structural and biophysical characteristics, and possess potential to initiate cross-seeding reactions. Importantly, unlike insulin fibrils, the aspartame–insulin coassembled fibrils were found to be peptidase-resistant and cytotoxic. The results indicate the interplay between insulin fibrillation and aspartame aggregation, which signifies a possible link between the progression of diabetes-associated complications and the consumption of aspartame.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biophysical and Biomaterials Research Laboratory, Room 310, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
- Biomolecular Self-Assembly Lab, Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603203, India.
ORCID-Profile: Masihuzzaman Ansari, Kailash Prasad Prajapati, Om Prakash Mahato, Bibin Gnanadhason Anand, Karunakar Kar
Zitieren
APA
Ansari, M., Prajapati, K. P., Mittal, S., Bhati, V., Gupta, V., Mishra, S., Patidar, S., Mahato, O. P., Bhandari, A. K., Anand, B. G., & Kar, K. (2025). Molecular Crosstalk between Artificial Sweetener Aspartame and Diabetes-Linked Insulin Hormone Unveils Possible Amyloidosis Risks. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c00286
Vancouver
Ansari M, Prajapati KP, Mittal S, Bhati V, Gupta V, Mishra S, et al. Molecular Crosstalk between Artificial Sweetener Aspartame and Diabetes-Linked Insulin Hormone Unveils Possible Amyloidosis Risks. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c00286
BibTeX
@article{Ansari2025,
author = {Ansari, Masihuzzaman and Prajapati, Kailash Prasad and Mittal, Shikha and Bhati, Vaishali and Gupta, Vartika and Mishra, Shraddha and Patidar, Swati and Mahato, Om Prakash and Bhandari, Aurgha Kamal and Anand, Bibin Gnanadhason and Kar, Karunakar},
title = {Molecular Crosstalk between Artificial Sweetener Aspartame and Diabetes-Linked Insulin Hormone Unveils Possible Amyloidosis Risks},
journal = {Biomacromolecules},
year = {2025},
doi = {10.1021/acs.biomac.5c00286}
}
EUVIMED